Bayer seeks European approval of extended 6-month treatment interval for Eylea 8 mg to treat nAMD & diabetic macular edema: Berlin Tuesday, February 11, 2025, 10:00 Hrs [IST] Baye ...

Bayer is committed to advancing treatment in prostate cancer care, showcasing new analyses from its comprehensive clinical trial program for NUBEQA ® (darolutamide), which includes the ARANOTE, ...

Nate Tice and Charles McDonald check in with their fifth mock draft of this cycle now that Super Bowl LIX is over and so is ...

The commonplace phenomenon of liquid drops falling from a surface is—perhaps surprisingly—not yet fully understood by ...

The 36-week trial was a randomized, double-masked, parallel-group, active-controlled, multicenter evaluating CLS-AX (axitinib ...

The distinct population of endothelial cells that line blood vessels in the insulin-producing "islets" of the human pancreas ...

The cure rate for [diffuse midline glioma] is less than 1%, and the median overall survival is nine to 11 months,” said Dr.

The recently approved device simplifies operator manipulations by loading a balloon and filter onto the stent.

For decades, scientists across the globe have investigated methods to accurately measure drug permeability across the blood-brain barrier, a compact layer of cells that protect the brain from ...